Skip to the page

Data / Form D filings / MODULO BIO, INC.

MODULO BIO, INC.: Form D filings

MODULO BIO, INC., a pharmaceuticals company in Los Altos, CA, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on November 20, 2024, reports $5.8 million sold of a $7.5 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1525 KENSINGTON, Los Altos, CA, 94024
Phone
(650) 787-8325
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1867562

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 20, 2024New notice$7,500,000$5,845,788$1,654,2123Nov 6, 2024sec.gov
Jun 15, 2021New notice$4,000,000$3,909,992$90,00811Jun 8, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nicholas Leu SaccomanoDirector
Alda Leu DennisDirector
Alexander Scott PattersonDirector
Michael HorowitzExecutive Officer, Director

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Nov 18, 2024 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what MODULO BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.